TIMI 4 compared the efficacy of front loaded tPA vs. APSAC vs. the combination of reduced dose tPA and APSAC for treatment of patients presenting within 6 hours of onset of ST elevation myocardial infarction.
MAIN RESULTS:
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial
J Am Coll Cardiol. 1994 Dec;24(7):1602-10.
PRESENTATIONS
OTHER PUBLICATIONS
Seasonal variation of myocardial infarct size. Am J Cardiol. 2001 Nov 1;88(9):1021-4.